| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442964 | European Journal of Cancer | 2014 | 10 Pages |
Abstract
Fewer recurrences occurred after treatment of high risk facial BCC with MMS compared to treatment with SE. The proportion of recurrences occurring more than 5Â years post-treatment was especially high for pBCC, stressing the need for long-term follow-up in patients with high risk facial pBCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eva van Loo, Klara Mosterd, Gertruud A.M. Krekels, Marieke H. Roozeboom, Judith U. Ostertag, Carmen D. Dirksen, Peter M. Steijlen, H.A. Martino Neumann, Patty J. Nelemans, Nicole W.J. Kelleners-Smeets,